Suppression of T-cell chemokines by Porphyromonas gingivalis

Infection and Immunity

Volumn 81, Issue 7, 2013, Pages 2288-2295

  Jauregui, Catherine E ^a   Wang, Qian ^a   Wright, Christopher J ^a   Takeuchi, Hiroki ^a   Uriarte, Silvia M ^b   Lamont, Richard J ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; STAT1 PROTEIN;

ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EPITHELIUM CELL; FUSOBACTERIUM NUCLEATUM; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MIXED INFECTION; NEUTROPHIL; NONHUMAN; PERIODONTAL DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PORPHYROMONAS GINGIVALIS; PORPHYROMONAS GINGIVALIS INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

BACTEROIDACEAE INFECTIONS; CELLS, CULTURED; CHEMOKINE CXCL10; CHEMOKINE CXCL11; CHEMOKINE CXCL9; EPITHELIAL CELLS; FUSOBACTERIUM INFECTIONS; FUSOBACTERIUM NUCLEATUM; GINGIVA; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; PORPHYROMONAS GINGIVALIS; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 84879458372     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00264-13     Document Type: Article

References (52)

1. Eke P I, Dye B A, Wei L, Thornton-Evans G O, Genco R J. 2012. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J. Dent. Res. 91:914 -920
2. Darveau R P, Hajishengallis G, Curtis M A. 2012. Porphyromonas gingivalis as a potential community activist for disease. J. Dent. Res. 91:816-820
3. Hajishengallis G, Lamont R J. 2012. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol. Oral Microbiol. 27:409-419
4. Whitmore S E, Lamont R J. 2011. The pathogenic persona of communityassociated oral streptococci. Mol. Microbiol. 81:305-314
5. Byrne S J, Dashper S G, Darby I B, Adams G G, Hoffmann B, Reynolds E C. 2009. Progression of chronic periodontitis can be predicted by the levels of Porphyromonas gingivalis and Treponema denticola in subgingival plaque. Oral Microbiol. Immunol. 24:469-477
6. Lamont R J, Jenkinson H F. 1998. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev. 62: 1244-1263
7. Kuboniwa M, Lamont R J. 2010. Subgingival biofilm formation. Periodontol. 2000 52:38 -52
8. Wright C J, Burns L H, Jack A A, Back C R, Dutton L C, Nobbs A H, Lamont R J, Jenkinson H F. 2013. Microbial interactions in building of communities. Mol. Oral Microbiol. 28:83-101
9. Daep C A, Novak E A, Lamont R J, Demuth D R. 2011. Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii. Infect. Immun. 79:67-74
10. Hajishengallis G, Darveau R P, Curtis M A. 2012. The keystone-pathogen hypothesis. Nat. Rev. Microbiol. 10:717-725
11. Tribble G D, Lamont R J. 2010. Bacterial invasion of epithelial cells and spreading in periodontal tissue. Periodontol. 2000 52:68-83
12. Handfield M, Mans J J, Zheng G, Lopez M C, Mao S, Progulske-Fox A, Narasimhan G, Baker H V, Lamont RJ. 2005. Distinct transcriptional profiles characterize oral epithelium-microbiota interactions. Cell. Microbiol. 7:811- 823
13. Handfield M, Baker H V, Lamont R J. 2008. Beyond good and evil in the oral cavity: insights into host-microbe relationships derived from transcriptional profiling of gingival cells. J. Dent. Res. 87:203-223
14. Darveau RP, Belton CM, Reife RA, Lamont RJ. 1998. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect. Immun. 66:1660 -1665
15. Hasegawa Y, Tribble GD, Baker HV, Mans JJ, Handfield M, Lamont RJ. 2008. Role of Porphyromonas gingivalis SerB in gingival epithelial cell cytoskeletal remodeling and cytokine production. Infect. Immun. 76:2420-2427
16. Coats SR, Berezow AB, To TT, Jain S, Bainbridge BW, Banani KP, Darveau RP. 2011. The lipid A phosphate position determines differential host Toll-like receptor 4 responses to phylogenetically related symbiotic and pathogenic bacteria. Infect. Immun. 79:203-210
17. Jain S, Darveau RP. 2010. Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis. Periodontol. 2000 54:53-70
18. Hajishengallis G, Lambris JD. 2011. Microbial manipulation of receptor crosstalk in innate immunity. Nat. Rev. Immunol. 11:187-200
19. Wang M, Krauss JL, Domon H, Hosur KB, Liang S, Magotti P, Triantafilou M, Triantafilou K, Lambris JD, Hajishengallis G. 2010. Microbial hijacking of complement-toll-like receptor crosstalk. Sci. Signal. 3:ra11.
20. Liang S, Krauss JL, Domon H, McIntosh ML, Hosur KB, Qu H, Li F, Tzekou A, Lambris JD, Hajishengallis G. 2011. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J. Immunol. 186:869-877
21. Gaffen S L, Hajishengallis G. 2008. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J. Dent. Res. 87:817- 828
22. Teng Y T. 2006. Protective and destructive immunity in the periodonticum. Part 2. T-cell-mediated immunity in the periodontium. J. Dent. Res. 85:209 -219
23. Gemmell E, Yamazaki K, Seymour G J. 2007. The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol. 2000 43:14-40
24. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203:2673-2682
25. Garlet G P. 2010. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J. Dent. Res. 89:1349 -1363
26. Groom J R, Luster A D. 2011. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89:207-215
27. Moutsopoulos N M, Kling H M, Angelov N, Jin W, Palmer R J, Nares S, Osorio M, Wahl S M. 2012. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J. Autoimmun. 39:294 -303
28. Gaddis D E, Maynard C L, Weaver C T, Michalek S M, Katz J. 2013. Role of TLR2-dependent IL-10 production in the inhibition of the initial IFNgamma T cell response to Porphyromonas gingivalis. J. Leukoc. Biol. 93: 21-31
29. Khalaf H, Bengtsson T. 2012. Altered T-cell responses by the periodontal pathogen Porphyromonas gingivalis. PLoS One 7:e45192.
30. Sandros J, Karlsson C, Lappin DF, Madianos PN, Kinane DF, Papapanou PN. 2000. Cytokine responses of oral epithelial cells to Porphyromonas gingivalis infection. J. Dent. Res. 79:1808 -1814
31. Fitzpatrick RE, Wijeyewickrema LC, Pike RN. 2009. The gingipains: scissors and glue of the periodontal pathogen, Porphyromonas gingivalis. Future Microbiol. 4:471- 487
32. Guo Y, Nguyen KA, Potempa J. 2010. Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. Periodontol. 2000 54:15- 44
33. Moffatt-Jauregui CE, Robinson B, de Moya AV, Brockman RD, Roman AV, Cash MN, Culp DJ, Lamont RJ. Establishment and characterization of a telomerase immortalized human gingival epithelial cell line. J. Periodontal Res., in press
34. Uriarte SM, Rane MJ, Luerman GC, Barati MT, Ward RA, Nauseef WM, McLeish KR. 2011. Granule exocytosis contributes to priming and activation of the human neutrophil respiratory burst. J. Immunol. 187: 391-400
35. Shultz DB, Rani MR, Fuller JD, Ransohoff RM, Stark GR. 2009. Roles of IKK-beta, IRF1, and p65 in the activation of chemokine genes by interferon-gamma. J. Interferon Cytokine Res. 29:817- 824
36. Liu M, Guo S, Hibbert JM, Jain V, Singh N, Wilson NO, Stiles JK. 2011. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 22:121-130
37. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. 2002. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168:3195-3204
38. Kabashima H, Yoneda M, Nagata K, Hirofuji T, Maeda K. 2002. The presence of chemokine (MCP-1, MIP-1alpha, MIP-1beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues. Cytokine 20:70 -77
39. Garlet GP, Martins W, Jr, Ferreira BR, Milanezi CM, Silva JS. 2003. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J. Periodontal Res. 38:210 -217
40. Gemmell E, Carter CL, Seymour GJ. 2001. Chemokines in human periodontal disease tissues. Clin. Exp. Immunol. 125:134 -141
41. Crawford MA, Lowe DE, Fisher DJ, Stibitz S, Plaut RD, Beaber JW, Zemansky J, Mehrad B, Glomski IJ, Strieter RM, Hughes MA. 2011. Identification of the bacterial protein FtsX as a unique target of chemokine-mediated antimicrobial activity against Bacillus anthracis. Proc. Natl. Acad. Sci. U. S. A. 108:17159 -17164
42. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ. 2003. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J. Leukoc. Biol. 74:448-455
43. Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM. 2001. Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J. Immunol. 167:623- 627
44. Zhang HM, Yuan J, Cheung P, Chau D, Wong BW, McManus BM, Yang D. 2005. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression. Mol. Cell. Biol. 25:6247- 6258
45. Mao S, Park Y, Hasegawa Y, Tribble GD, James CE, Handfield M, Stavropoulos MF, Yilmaz O, Lamont RJ. 2007. Intrinsic apoptotic pathways of gingival epithelial cells modulated by Porphyromonas gingivalis. Cell. Microbiol. 9:1997-2007
46. Nakhjiri SF, Park Y, Yilmaz O, Chung WO, Watanabe K, El-Sabaeny A, Park K, Lamont RJ. 2001. Inhibition of epithelial cell apoptosis by Porphyromonas gingivalis. FEMS Microbiol. Lett. 200:145-149
47. Qian C, An H, Yu Y, Liu S, Cao X. 2007. TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and inhibit Th1 proliferation. Blood 109:3308 -3315
48. Peyyala R, Kirakodu SS, Novak KF, Ebersole JL. 2012. Oral microbial biofilm stimulation of epithelial cell responses. Cytokine 58:65-72
49. Jotwani R, Pulendran B, Agrawal S, Cutler CW. 2003. Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro. Eur. J. Immunol. 33:2980 -2986
50. Oido-Mori M, Rezzonico R, Wang PL, Kowashi Y, Dayer JM, Baehni PC, Chizzolini C. 2001. Porphyromonas gingivalis gingipain-R enhances interleukin-8 but decreases gamma interferon-inducible protein 10 production by human gingival fibroblasts in response to T-cell contact. Infect. Immun. 69:4493- 4501
51. Pyrc K, Milewska A, Kantyka T, Sroka A, Maresz K, Koziel J, Nguyen KA, Enghild JJ, Knudsen AD, Potempa J. 2013. Inactivation of epidermal growth factor by Porphyromonas gingivalis as a potential mechanism for periodontal tissue damage. Infect. Immun. 81:55- 64
52. Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL, Lambris JD, Darveau RP, Curtis MA. 2011. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10:497-506.